For locally recurrent disease after surgical resection of EGFR/ALK positive NSCLC that appears suitable for chemoradiation, would you proceed directly to chemoradiation or consider TKI first?  

Does timing of recurrence (early vs late) factor into your decision and would you consider consolidation durvalumab?  



Answer from: Medical Oncologist at Community Practice